AI & ChatGPT searches , social queries for TEPOTINIB
Search references for TEPOTINIB. Phrases containing TEPOTINIB
See searches and references containing TEPOTINIB!
Search references for TEPOTINIB. Phrases containing TEPOTINIB
See searches and references containing TEPOTINIB!TEPOTINIB
Chemical compound
Tepotinib, sold under the brand name Tepmetko, is an anti-cancer medication used for the treatment of adults with non-small cell lung cancer (NSCLC).
Tepotinib
Malignant tumor characterized by uncontrolled cell growth in lung tissue
overactive MET, which can be inhibited with MET inhibitors capmatinib or tepotinib. Targeted therapies are also available for some cancers with rare mutations
Lung_cancer
Medication
Selpercatinib Sitravatinib Sorafenib Sunitinib Surufatinib Tebentafusp Tepotinib Toceranib Tunlametinib Umbralisib Vandetanib Venetoclax Vimseltinib
Elranatamab
Pharmaceutical drug classification
Pemigatinib L01EN03 Infigratinib L01EN04 Futibatinib L01EP01 Capmatinib L01EP02 Tepotinib L01EP03 Savolitinib L01EX01 Sunitinib L01EX02 Sorafenib L01EX03 Pazopanib
ATC_code_L01
Class of compounds
approval to treat kidney cancer. Tepotinib (MSC 2156119J) has reported phase II clinical trial results on lung cancer. Tepotinib was granted breakthrough therapy
C-Met_inhibitor
Monoclonal antibody
Selpercatinib Sitravatinib Sorafenib Sunitinib Surufatinib Tebentafusp Tepotinib Toceranib Tunlametinib Umbralisib Vandetanib Venetoclax Vimseltinib
Mosunetuzumab
TEPOTINIB
TEPOTINIB
TEPOTINIB
TEPOTINIB
TEPOTINIB
TEPOTINIB
TEPOTINIB
TEPOTINIB
TEPOTINIB